Topical AK, non-melanoma cancer options show promise


Newport Beach, Calif. — When it comes to potential topical treatments for actinic keratoses (AKs) and non-melanoma skin cancers, T4N5 liposome lotion (Dimericine, Applied Genetics Inc. Dermatics) leads the pack. The product is composed of the protein T4 endonuclease V in a liposome vehicle.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.